The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

More than 600,000 Americans were hospitalized due to flu-related illness last year, according to the CDC. The mRNA-1010 vaccine's safety data was consistent with previous results from another phase ...

anti-vaccine After RFK Jr. overhauls CDC panel, measles and flu vaccines are up for debate The new ACIP agenda includes MMRV and thimerosal-containing flu vaccines.

CDC officials have information about underlying conditions on nearly 5,200 adults who were hospitalized with flu this season, and 95% had at least one existing health problem.